Last reviewed · How we verify
Lanthanum carbonate hydrate — Competitive Intelligence Brief
phase 1
Small molecule
Live · refreshed every 30 min
Target snapshot
Lanthanum carbonate hydrate (Lanthanum carbonate hydrate) — Astellas Pharma Inc.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Lanthanum carbonate hydrate TARGET | Lanthanum carbonate hydrate | Astellas Pharma Inc | phase 1 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Lanthanum carbonate hydrate CI watch — RSS
- Lanthanum carbonate hydrate CI watch — Atom
- Lanthanum carbonate hydrate CI watch — JSON
- Lanthanum carbonate hydrate alone — RSS
Cite this brief
Drug Landscape (2026). Lanthanum carbonate hydrate — Competitive Intelligence Brief. https://druglandscape.com/ci/lanthanum-carbonate-hydrate. Accessed 2026-05-17.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab